Chris Cummings

Interest
Life sciences

Chris is an Entrepreneur in Residence. Chris joined Bay after 10 years in start-up and mid-size biotechnology. Most recently he was co-founder of EnVivo Pharmaceuticals Inc., a clinical stage biopharmaceutical company dedicated to discovering and developing drugs for central nervous system disorders. Prior, Chris held research and project leadership positions at AGY Therapeutics and Genencor International.

Education
B.A., University of California, Santa Barbara
Ph.D., Baylor College of Medicine

Contact


Assistant
Dianne Brewer-Donnelly